Ignite Creation Date:
2024-05-05 @ 6:38 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00519467
Status:
COMPLETED
Last Update Posted:
2016-12-06
First Post:
2007-08-20
Brief Title:
Safety and Efficacy Dose of Artesunate Used in Combination With LAPDAP Treatment of Uncomplicated Falciparum Malaria
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline